Sensitive liquid chromatography tandem mass spectrometry method for the quantification of Quetiapine in plasma. 2008

Ramakrishna Nirogi, and Gopinadh Bhyrapuneni, and Vishwottam Kandikere, and Koteshwara Mudigonda, and Devender Ajjala, and K Mukkanti
Pharmacokinetics and Drug Metabolism, Drug Discovery, Suven Life Sciences Ltd, Serene Chambers, Road 5, Avenue 7, Banjara Hills, Hyderabad 500034, India. ramakrishna_nirogi@yahoo.co.in

A sensitive high-performance liquid chromatography-tandem mass spectrometry method was developed and validated for the quantification of quetiapine in rat plasma. Following liquid-liquid extraction, the analyte was separated using a gradient mobile phase on a reverse-phase column and analyzed by MS/MS in the multiple reaction monitoring mode using the respective [M + H]+ ions, m/z 384 to m/z 221 for quetiapine and m/z 327 to m/z 270 for the internal standard. The assay exhibited a linear dynamic range of 0.25-500 ng/mL for quetiapine in rat plasma. The lower limit of quantification was 0.25 ng/mL with a relative standard deviation of less than 7%. Acceptable precision and accuracy were obtained for concentrations over the standard curve range. The validated method was successfully used to analyze rat plasma samples for application in pre-clinical pharmacokinetic studies. This method in rodent plasma could be adapted for quetiapine assay in human plasma.

UI MeSH Term Description Entries
D002851 Chromatography, High Pressure Liquid Liquid chromatographic techniques which feature high inlet pressures, high sensitivity, and high speed. Chromatography, High Performance Liquid,Chromatography, High Speed Liquid,Chromatography, Liquid, High Pressure,HPLC,High Performance Liquid Chromatography,High-Performance Liquid Chromatography,UPLC,Ultra Performance Liquid Chromatography,Chromatography, High-Performance Liquid,High-Performance Liquid Chromatographies,Liquid Chromatography, High-Performance
D003987 Dibenzothiazepines
D000069348 Quetiapine Fumarate A dibenzothiazepine and ANTIPSYCHOTIC AGENT that targets the SEROTONIN 5-HT2 RECEPTOR; HISTAMINE H1 RECEPTOR, adrenergic alpha1 and alpha2 receptors, as well as the DOPAMINE D1 RECEPTOR and DOPAMINE D2 RECEPTOR. It is used in the treatment of SCHIZOPHRENIA; BIPOLAR DISORDER and DEPRESSIVE DISORDER. 2-(2-(4-dibenzo(b,f)(1,4)thiazepine-11-yl-1-piperazinyl)ethoxy)ethanol,Ethanol, 2-(2-(4-dibenzo(b,f)(1,4)thiazepin-11-yl-1-piperazinyl)ethoxy)-, (E)-2-butenedioate (2:1) (salt),ICI 204,636,ICI 204636,ICI-204636,Quetiapine,Seroquel,ICI204636
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D015203 Reproducibility of Results The statistical reproducibility of measurements (often in a clinical context), including the testing of instrumentation or techniques to obtain reproducible results. The concept includes reproducibility of physiological measurements, which may be used to develop rules to assess probability or prognosis, or response to a stimulus; reproducibility of occurrence of a condition; and reproducibility of experimental results. Reliability and Validity,Reliability of Result,Reproducibility Of Result,Reproducibility of Finding,Validity of Result,Validity of Results,Face Validity,Reliability (Epidemiology),Reliability of Results,Reproducibility of Findings,Test-Retest Reliability,Validity (Epidemiology),Finding Reproducibilities,Finding Reproducibility,Of Result, Reproducibility,Of Results, Reproducibility,Reliabilities, Test-Retest,Reliability, Test-Retest,Result Reliabilities,Result Reliability,Result Validities,Result Validity,Result, Reproducibility Of,Results, Reproducibility Of,Test Retest Reliability,Validity and Reliability,Validity, Face
D017208 Rats, Wistar A strain of albino rat developed at the Wistar Institute that has spread widely at other institutions. This has markedly diluted the original strain. Wistar Rat,Rat, Wistar,Wistar Rats
D051381 Rats The common name for the genus Rattus. Rattus,Rats, Laboratory,Rats, Norway,Rattus norvegicus,Laboratory Rat,Laboratory Rats,Norway Rat,Norway Rats,Rat,Rat, Laboratory,Rat, Norway,norvegicus, Rattus
D053719 Tandem Mass Spectrometry A mass spectrometry technique using two (MS/MS) or more mass analyzers. With two in tandem, the precursor ions are mass-selected by a first mass analyzer, and focused into a collision region where they are then fragmented into product ions which are then characterized by a second mass analyzer. A variety of techniques are used to separate the compounds, ionize them, and introduce them to the first mass analyzer. For example, for in GC-MS/MS, GAS CHROMATOGRAPHY-MASS SPECTROMETRY is involved in separating relatively small compounds by GAS CHROMATOGRAPHY prior to injecting them into an ionization chamber for the mass selection. Mass Spectrometry-Mass Spectrometry,Mass Spectrometry Mass Spectrometry,Mass Spectrometry, Tandem
D021241 Spectrometry, Mass, Electrospray Ionization A mass spectrometry technique used for analysis of nonvolatile compounds such as proteins and macromolecules. The technique involves preparing electrically charged droplets from analyte molecules dissolved in solvent. The electrically charged droplets enter a vacuum chamber where the solvent is evaporated. Evaporation of solvent reduces the droplet size, thereby increasing the coulombic repulsion within the droplet. As the charged droplets get smaller, the excess charge within them causes them to disintegrate and release analyte molecules. The volatilized analyte molecules are then analyzed by mass spectrometry. ESI Mass Spectrometry,Electrospray Ionization Mass Spectrometry,Mass Spectrometry, ESI,Spectrometry, ESI Mass

Related Publications

Ramakrishna Nirogi, and Gopinadh Bhyrapuneni, and Vishwottam Kandikere, and Koteshwara Mudigonda, and Devender Ajjala, and K Mukkanti
December 2005, Biomedical chromatography : BMC,
Ramakrishna Nirogi, and Gopinadh Bhyrapuneni, and Vishwottam Kandikere, and Koteshwara Mudigonda, and Devender Ajjala, and K Mukkanti
January 2024, Methods in molecular biology (Clifton, N.J.),
Ramakrishna Nirogi, and Gopinadh Bhyrapuneni, and Vishwottam Kandikere, and Koteshwara Mudigonda, and Devender Ajjala, and K Mukkanti
September 2013, Journal of pharmaceutical and biomedical analysis,
Ramakrishna Nirogi, and Gopinadh Bhyrapuneni, and Vishwottam Kandikere, and Koteshwara Mudigonda, and Devender Ajjala, and K Mukkanti
October 2008, Biomedical chromatography : BMC,
Ramakrishna Nirogi, and Gopinadh Bhyrapuneni, and Vishwottam Kandikere, and Koteshwara Mudigonda, and Devender Ajjala, and K Mukkanti
October 2007, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences,
Ramakrishna Nirogi, and Gopinadh Bhyrapuneni, and Vishwottam Kandikere, and Koteshwara Mudigonda, and Devender Ajjala, and K Mukkanti
May 2005, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences,
Ramakrishna Nirogi, and Gopinadh Bhyrapuneni, and Vishwottam Kandikere, and Koteshwara Mudigonda, and Devender Ajjala, and K Mukkanti
February 2006, Journal of pharmaceutical and biomedical analysis,
Ramakrishna Nirogi, and Gopinadh Bhyrapuneni, and Vishwottam Kandikere, and Koteshwara Mudigonda, and Devender Ajjala, and K Mukkanti
January 2006, Rapid communications in mass spectrometry : RCM,
Ramakrishna Nirogi, and Gopinadh Bhyrapuneni, and Vishwottam Kandikere, and Koteshwara Mudigonda, and Devender Ajjala, and K Mukkanti
May 2007, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences,
Ramakrishna Nirogi, and Gopinadh Bhyrapuneni, and Vishwottam Kandikere, and Koteshwara Mudigonda, and Devender Ajjala, and K Mukkanti
September 2021, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences,
Copied contents to your clipboard!